Life at the Johns Hopkins School of Medicine
In the world of HIV, two fundamental equations define our understanding. The first is “undetectable = untransmissible,” meaning that when the viral load of person… Read More »Conference on Retroviruses and Opportunistic Infections 2025: A Week of Science, Community and Protest
Why global neurology? In a presentation featured by the Johns Hopkins Alumni Association, Dr. Deanna Saylor addresses the answer to this question and shares her experiences developing neurologic research, care and training in Zambia.
Imagine going to the doctor to be tested for HIV in sub-Saharan Africa. You will likely have to travel a long distance to get to… Read More »Mobile Phones Can Make the Difference for Infectious Disease Management
In November 2015, the FDA approved the HIV-1 medication Genvoya, a once-daily pill containing fixed doses of the HIV drugs elvitegravir, cobicistat, emtricitabine and tenofovir… Read More »Once-Daily Combination Pills Offer More Than Convenience
A potential tool to combat the HIV epidemic in Baltimore is gaining attention, and it may involve an unlikely location — the church. Researchers at… Read More »Church Attendance Could Lower HIV Rates in High-Risk Women